HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA203561 (SCIEGEN PHARMS)
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA203561 (SCIEGEN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; Application number: ANDA203561.
| Brand name | HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE |
| Application number | ANDA203561 |
| Sponsor | SCIEGEN PHARMS |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20190114 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →